Care Plans, Education Improve Long-term Quality of Life
“With 1 in 3 individuals receiving a cancer diagnosis sometime during their lifetime, we all are likely to experience cancer ourselves or to have a relative or close friend with cancer. Fortunately, there have been vast improvements in treatments and care for patients with cancer. But with those successful treatments often come short- and long-term toxicities that must be managed.”
Targeted Therapy Shows Promise for Lung Cancers With Brain Metastases, Small Trial Suggests
“Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC).”
Fewer black veterans complete referrals for lung cancer screening
“Black veterans have significantly lower odds of completing lung cancer screening (LCS) than White veterans even after adjusting for demographic and socioeconomic risk factors, according to a study published online June 16 in JAMA Network Open.”
Pemigatinib Shows Antitumor Activity in Tumors Harboring FGFR Alterations
“Advanced/metastatic or unresectable solid tumors harboring activating FGFR mutations or fusions/rearrangements responded to pemigatinib (Pemazyre), according to data from the phase 2 FIGHT-207 trial (NCT03822117; EudraCT 2018004768-69),” reported at the American Association for Cancer Research Annual Meeting 2023.”
Does smoking marijuana increase lung cancer risk?
“Marijuana laws are changing rapidly across many states, and researchers have found that legalization increases its use by about 20%. It’s a widely used substance and the most commonly used federally illegal drug in the U.S. In 2019, about 49 million people age 12 and older in the U.S. used marijuana in the previous 12 months.”
Consecutive Negative Lung Cancer Screening Results Breed Nonadherence to Follow-up
“A recent study showed that people who had negative results on consecutive lung cancer screening tests were less likely to adhere to follow-up recommendations. These study findings were reported in JAMA Network Open.”
Lung Cancer Research Foundation and ALK Positive Announce New Research Partnership
“NEW YORK, June 15, 2023 /PRNewswire/ — The Lung Cancer Research Foundation (LCRF) and the ALK Positive Inc. (ALK Positive) announce the expansion of its current research partnership to fund $2 million in ALK-positive related lung cancer projects over three years. The aim of this research is to advance high-impact research focused upon transforming care and improving outcomes for patients with ALK-positive non-small cell lung cancer (NSCLC).”
Diet May Have Big Effect on Common Lung Cancer Treatment
“Eating a more substantial meal led to significantly higher blood concentrations of drug in patients taking an often-prescribed treatment for lung cancer. Alectinib (Genentech’s Alecensa) is a small molecule kinase inhibitor used to treat ALK positive, metastatic, non-small cell lung cancer. Taking a dose of alectinib with a small, low-fat snack instead of a more generous meal left more than a third of patients below the drug concentration goal.”
Pioneering methodology reveals novel biomarkers for non-small cell lung cancer
“Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia (IBEC) have identified new biomarkers for non-small cell lung cancer, the most common lung cancer. The results, published in the journal Modern Pathology, have been obtained thanks to a new technique that allows quantitative analysis of patient samples. It is a pioneering methodology that is cheaper and easier to apply than the traditional ones in hospitals and other clinical settings.”
Video:
‘There’s a Lot of Innovation’ in the KRAS-Mutant Lung Cancer Space
“The ongoing SPARK study (which is a collaborative effort among the GO2 for Lung Cancer Foundation, ALCMI and Dr. Mark Award and colleagues at the Dana-Farber Cancer Institute and Foundation Medicine) is attempting to lay the groundwork to fill the unmet needs.”
